Approximately 1 in 20 individuals diagnosed with RSV in outpatient settings were hospitalised within 28 days. Read more.

Positive interim Phase 1 data indicate APG808 was well-tolerated with half-life of approximately 55 days, supporting potential for 2- to 3- month ...

NCR, there has been a huge surge in the demand for respiratory drugs like Foracort, which has emerged as the top-selling ...

Inhaled therapy has become a crucial treatment option for respiratory diseases like asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD), delivering drugs directly to bronchial ...

The first new treatment for asthma attacks in 50 years is a drug already available—and it’s 4x more effective than steroid ...

I was diagnosed with COPD last year after struggling with multiple symptoms. I quit smoking over 10 years ago, but I'm ...

To gather further insights into these complex interactions, we welcome articles addressing, but not limited to, the following themes: o Influence of biodiversity loss on respiratory diseases, ...

The study demonstrated that asthma treatment is safe, with no significant side effects compared to past studies of the drug.

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...

For the first time in 50 years, a new treatment has been found to improve care for people experiencing asthma or COPD ...

King's College London (KCL) has announced the development of a "game-changer" injection it says is the first new treatment ...

A new study, supported by AstraZeneca, has shown that a single dose of benralizumab significantly reduces treatment failure ...